Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment
International Journal of Molecular Sciences · 14.11.2024 · 25 (22) · 12223
DOI: 10.3390/ijms252212223 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.11.2024. Verfasst von Jing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, The Fourth Military Medical University, Xi'an 710032, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Young Talent Fund of Association for Science and Technology in Shaanxi, Teaching and Research Program, School of Basic Medical Sciences, Air Force Medical University.
Abstract (Originalsprache)
Metabolic reprogramming of immune cells within the tumor microenvironment (TME) plays a pivotal role in shaping tumor progression and responses to therapy. The intricate interplay between tumor cells and immune cells within this ecosystem influences their metabolic landscapes, thereby modulating the immune evasion tactics employed by tumors and the efficacy of immunotherapeutic interventions. This review delves into the metabolic reprogramming that occurs in tumor cells and a spectrum of immune cells, including T cells, macrophages, dendritic cells, and myeloid-derived suppressor cells (MDSCs), within the TME. The metabolic shifts in these cell types span alterations in glucose, lipid, and amino acid metabolism. Such metabolic reconfigurations can profoundly influence immune cell function and the mechanisms by which tumors evade immune surveillance. Gaining a comprehensive understanding of the metabolic reprogramming of immune cells in the TME is essential for devising novel cancer therapeutic strategies. By targeting the metabolic states of immune cells, it is possible to augment their anti-tumor activities, presenting new opportunities for immunotherapeutic approaches. These strategies hold promise for enhancing treatment outcomes and circumventing the emergence of drug resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, The Fourth Military Medical University, Xi'an 710032, China.
ORCID-Profile: Shuya Yang
Förderung
- National Natural Science Foundation of China
- Young Talent Fund of Association for Science and Technology in Shaanxi
- Teaching and Research Program, School of Basic Medical Sciences, Air Force Medical University
- Teaching and Research Program, School of Basic Medical Sciences, Air Force Military Medical University
Zitieren
APA
Wang, J., He, Y., Hu, F., Hu, C., Sun, Y., Yang, K., & Yang, S. (2024). Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment. International Journal of Molecular Sciences, 25(22), 12223. https://doi.org/10.3390/ijms252212223
Vancouver
Wang J, He Y, Hu F, Hu C, Sun Y, Yang K, et al. Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment. International Journal of Molecular Sciences. 2024;25(22):12223. doi:10.3390/ijms252212223
BibTeX
@article{Wang2024,
author = {Wang, Jing and He, Yuanli and Hu, Feiming and Hu, Chenchen and Sun, Yuanjie and Yang, Kun and Yang, Shuya},
title = {Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {22},
pages = {12223},
doi = {10.3390/ijms252212223}
}
EUVIMED